Literature DB >> 23174372

Human microbial challenge: the ultimate animal model.

Andrew J Pollard, Julian Savulescu, John Oxford, Adrian Vs Hill, Myron M Levine, David Jm Lewis, Robert C Read, David Y Graham, Wellington Sun, Peter Openshaw, Stephen B Gordon.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 23174372     DOI： 10.1016/S1473-3099(12)70292-X

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN： 1473-3099            Impact factor:   25.071


× No keyword cloud information.
  18 in total

1.  Deliberate Microbial Infection Research Reveals Limitations to Current Safety Protections of Healthy Human Subjects.

Authors:  David L Evers; Carol B Fowler; Jeffrey T Mason; Rebecca K Mimnall
Journal:  Sci Eng Ethics       Date:  2014-08-24       Impact factor: 3.525

2.  Ethical Criteria for Human Challenge Studies in Infectious Diseases.

Authors:  Ben Bambery; Michael Selgelid; Charles Weijer; Julian Savulescu; Andrew J Pollard
Journal:  Public Health Ethics       Date:  2015-09-27       Impact factor: 1.940

Review 3.  The exceptionally broad-based potential of active and passive vaccination targeting the conserved microbial surface polysaccharide PNAG.

Authors:  David Skurnik; Colette Cywes-Bentley; Gerald B Pier
Journal:  Expert Rev Vaccines       Date:  2016-03-16       Impact factor: 5.217

4.  Pathogen recognition receptor crosstalk in respiratory syncytial virus sensing: a host and cell type perspective.

Authors:  Nico Marr; Stuart E Turvey; Nathalie Grandvaux
Journal:  Trends Microbiol       Date:  2013-10-09       Impact factor: 17.079

Review 5.  The potential for a controlled human infection platform in Singapore.

Authors:  Shobana Balasingam; Peter Horby; Annelies Wilder-Smith
Journal:  Singapore Med J       Date:  2014-09       Impact factor: 1.858

6.  Impaired Antibody-mediated Protection and Defective IgA B-Cell Memory in Experimental Infection of Adults with Respiratory Syncytial Virus.

Authors:  Maximillian S Habibi; Agnieszka Jozwik; Spyridon Makris; Jake Dunning; Allan Paras; John P DeVincenzo; Cornelis A M de Haan; Jens Wrammert; Peter J M Openshaw; Christopher Chiu
Journal:  Am J Respir Crit Care Med       Date:  2015-05-01       Impact factor: 30.528

7.  Neutrophilic inflammation in the respiratory mucosa predisposes to RSV infection.

Authors:  Maximillian S Habibi; Ryan S Thwaites; Christopher Chiu; Peter J M Openshaw; Meiping Chang; Agnieszka Jozwik; Allan Paras; Freja Kirsebom; Augusto Varese; Amber Owen; Leah Cuthbertson; Phillip James; Tanushree Tunstall; David Nickle; Trevor T Hansel; Miriam F Moffatt; Cecilia Johansson
Journal:  Science       Date:  2020-10-09       Impact factor: 63.714

8.  Lessons learnt from the first controlled human malaria infection study conducted in Nairobi, Kenya.

Authors:  Susanne H Hodgson; Elizabeth Juma; Amina Salim; Charles Magiri; Daniel Njenga; Sassy Molyneux; Patricia Njuguna; Ken Awuondo; Brett Lowe; Peter F Billingsley; Andrew O Cole; Caroline Ogwang; Faith Osier; Roma Chilengi; Stephen L Hoffman; Simon J Draper; Bernhards Ogutu; Kevin Marsh
Journal:  Malar J       Date:  2015-04-28       Impact factor: 2.979

9.  Three years of Extreme Physiology & Medicine.

Authors:  Michael P W Grocott; Hugh M Montgomery
Journal:  Extrem Physiol Med       Date:  2015-09-04

Review 10.  Using cross-species vaccination approaches to counter emerging infectious diseases.

Authors:  George M Warimwe; Michael J Francis; Thomas A Bowden; Samuel M Thumbi; Bryan Charleston
Journal:  Nat Rev Immunol       Date:  2021-06-17       Impact factor: 53.106
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.